Pharmaceuticals - Community Register


Community register of veterinary medicinal products


Product information

Invented name: Acticam   
Auth. number : EU/2/08/088
INN : Meloxicam
ATC: Anatomical main group: QM - Musculo-skeletal system
Therapeutic subgroup: QM01 - Antiinflammatory and antirheumatic products
Pharmacological subgroup: QM01A - Antiinflammatory and antirheumatic products, non-steroids
Chemical subgroup: QM01AC - Oxicams
Chemical substance: QM01AC06 - Meloxicam
(See WHO ATCvet Index)
Indication: Oral suspension: dogs: alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders.
Solution for injection: dogs: alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders; reduction of post-operative pain and inflammation following orthopaedic and soft tissue surgery.
Solution for injection: cats: reduction of postoperative pain after ovariohysterectomy and minor soft tissue surgery.
Marketing Authorisation Holder: Ecuphar NV
Legeweg 157-I, B-8020 Oostkamp, België

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which continues to be available in the Community Register.


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/12/2008 Centralised - Authorisation EMEA/V/C/138 (2008)8406 of 09/12/2008
28/10/2009 Centralised - Variation EMEA/V/C/138/IA/2
Updated with Decision(2010)2258 of 30/03/2010
01/04/2010 Centralised - Transfer Marketing Authorisation Holder EMEA/V/C/138/T/3 (2010)2258 of 30/03/2010
27/05/2010 Centralised - Variation EMEA/V/C/138/IA/5
28/05/2010 Centralised - Variation EMEA/V/C/138/IA/7
Updated with Decision(2010)6145 of 01/09/2010
28/05/2010 Centralised - Variation EMEA/V/C/138/IA/6
22/07/2010 Centralised - Variation EMEA/V/C/138/IB/4
Updated with Decision(2010)6145 of 01/09/2010
06/09/2010 Centralised - Variation (2010)6145 of 01/09/2010
03/01/2011 Centralised - Variation EMEA/V/C/138/IAin/9
26/01/2011 Centralised - Suspension of martketing authorisation EMEA/V/C/138/A-45/66 (2011)452 of 24/01/2011
04/04/2012 Centralised - Variation EMEA/V/C/138/IAin/10/G
Updated with Decision(2012)7206 of 10/10/2012
27/07/2012 Centralised - Variation EMEA/V/C/138/IA/11/G
Updated with Decision(2012)7206 of 10/10/2012
12/10/2012 Centralised - Variation (2012)7206 of 10/10/2012
11/12/2013 Centralised - Renewal EMEA/V/C/138/R/13 (2013)9149 of 09/12/2013